The sensitivity of ECL assays has not previously been adequate to quantify plasma NfL levels in AD (27), but advances in ultrasensitive detection in the ECL assays using additional signal enhancement (19) have made it possible to detect levels in the single picogram range using the current enhanced assay. This evidence concerns the gene NEFL and Alzheimer disease.